Publications by authors named "Benjamin Petsch"

Claim this Profile
A
An mRNA-based FimH nanoparticle vaccine against uropathogenic is highly immunogenic in rodents.
Sandro Roier, Roberto Adamo, Roberto Rosini, Alfredo Pezzicoli, Maria Scarselli, Benjamin Petsch

Front Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice.
Charlie Fricke, Lorenz Ulrich, Jana Kochmann, Janina Gergen, Kristina Kovacikova, Benjamin Petsch

Mol Ther Nucleic Acids· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Aerosols Transmit Prions to Immunocompetent and Immunodeficient Mice.

PLoS Pathog· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA-Based Vaccines Are Highly Immunogenic and Confer Protection in the Gnotobiotic Pig Model of Human Rotavirus Diarrhea.
Casey Hensley, Sandro Roier, Peng Zhou, Sofia Schnur, Charlotte Nyblade, Benjamin Petsch

Vaccines (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response.
Puthupparampil V Scaria, Nicole Roth, Kim Schwendt, Olga V Muratova, Nada Alani, Benjamin Petsch

NPJ Vaccines· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice.
Charlie Fricke, Florian Pfaff, Lorenz Ulrich, Nico Joel Halwe, Jacob Schön, Benjamin Petsch

Eur J Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents.
Sandro Roier, Vidya Mangala Prasad, Monica M McNeal, Kelly K Lee, Benjamin Petsch

NPJ Vaccines· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses.
Fredrika Hellgren, Alberto Cagigi, Rodrigo Arcoverde Cerveira, Sebastian Ols, Theresa Kern, Benjamin Petsch

Nat Commun· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses.
Fredrika Hellgren, Alberto Cagigi, Rodrigo Arcoverde Cerveira, Sebastian Ols, Theresa Kern, Benjamin Petsch

Nat Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models.
Lex G Medina-Magües, Janine Mühe, Edith Jasny, Emily S Medina-Magües, Nicole Roth, Benjamin Petsch

NPJ Vaccines· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models.
Björn Corleis, Donata Hoffmann, Susanne Rauch, Charlie Fricke, Nicole Roth, Benjamin Petsch

Nat Commun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA-Based Vaccines and Mode of Action.
Janina Gergen, Benjamin Petsch

Curr Top Microbiol Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models.
Nicole Roth, Janina Gergen, Kristina Kovacikova, Stefan O Mueller, Lorenz Ulrich, Benjamin Petsch

Vaccines (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses.
Klara Lenart, Fredrika Hellgren, Sebastian Ols, Xianglei Yan, Alberto Cagigi, Benjamin Petsch

Mol Ther Methods Clin Dev· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA vaccines induce rapid antibody responses in mice.
Makda S Gebre, Susanne Rauch, Nicole Roth, Janina Gergen, Jingyou Yu, Benjamin Petsch

NPJ Vaccines· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV conserved elements in macaques.
Antonio Valentin, Cristina Bergamaschi, Margherita Rosati, Matthew Angel, Robert Burns, Benjamin Petsch

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses.
Nicole Roth, Jacob Schön, Donata Hoffmann, Moritz Thran, Andreas Thess, Benjamin Petsch

Vaccines (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.
Makda S Gebre, Susanne Rauch, Nicole Roth, Jingyou Yu, Abishek Chandrashekar, Benjamin Petsch

Nature· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA Vaccine Protects against Zika Virus.
Lex G Medina-Magües, Janina Gergen, Edith Jasny, Benjamin Petsch, Jaime Lopera-Madrid

Vaccines (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA Vaccines Induce Rapid Antibody Responses in Mice.
Makda S Gebre, Susanne Rauch, Nicole Roth, Janina Gergen, Jingyou Yu, Benjamin Petsch

bioRxiv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates.
Neeltje van Doremalen, Robert J Fischer, Jonathan E Schulz, Myndi G Holbrook, Brian J Smith, Benjamin Petsch

Viruses· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of low dose prime-boost vaccination of mRNA vaccine CV07050101 in non-human primates.
Neeltje van Doremalen, Robert J Fischer, Jonathan E Schulz, Myndi G Holbrook, Brian J Smith, Benjamin Petsch

bioRxiv· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.
Donata Hoffmann, Björn Corleis, Susanne Rauch, Nicole Roth, Janine Mühe, Benjamin Petsch

Nat Commun· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents.
Susanne Rauch, Nicole Roth, Kim Schwendt, Mariola Fotin-Mleczek, Stefan O Mueller, Benjamin Petsch

NPJ Vaccines· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in RNA Vaccines for Preventive Indications: A Case Study of A Vaccine Against Rabies.
Nicole Armbruster, Edith Jasny, Benjamin Petsch

Vaccines (Basel)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis